You can buy or sell AC Immune and other stocks, options, ETFs, and crypto commission-free!
AC Immune SA Common Stock, also called AC Immune, is a clinical stage biopharmaceutical company, which engages in developing therapeutic and diagnostic products. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. Read More The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.
Lausanne, Basel-Landschaft (Basle Country)
52 Week High
52 Week Low
Simply Wall StMar 13
Such Is Life: How AC Immune (NASDAQ:ACIU) Shareholders Saw Their Shares Drop 60%
AC Immune SA (NASDAQ:ACIU) shareholders should be happy to see the share price up 19% in the last month. But that isn’t much consolation to those who have suffered through the declines of the last year. Like an arid lake in a warming world, shareholder value has evaporated, with the share price down 60% in that time. So the bounce should be viewed in that context. Arguably, the fall was overdone. See our latest analysis for AC Immune AC Immune isn’t currently profitable, so most analysts would look to rev...
$0.35 per share
Available Mar 21, Pre-Market